中文名称: | PKI-166 hydrochloride | ||||
---|---|---|---|---|---|
英文名称: | PKI-166 hydrochloride | ||||
别名: | PKI-166 hydrochloride PKI-166 hydrochloride | ||||
CAS No: | 2230253-82-2 | 分子式: | C20H19ClN4O | 分子量: | 366.84 |
CAS No: | 2230253-82-2 | ||||
分子式: | C20H19ClN4O | ||||
分子量: | 366.84 |
基本信息
产品编号:P30018 |
|||||
产品名称:PKI-166 hydrochloride |
|||||
CAS: |
2230253-82-2 |
储存条件 |
粉末 |
-20℃ |
四年 |
分子式: |
|||||
分子量 |
366.84 |
||||
化学名: |
4-[4-[[(1R)-1-Phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol hydrochloride |
生物活性
产品描述 |
一种高效、选择性的,具有口服生物活性的EGFR酪氨酸激酶抑制剂,IC50值为0.7nM。 |
|
靶点/IC50 |
IC50: 0.7nM (EGFR tyrosine kinase) |
|
体外研究 |
PKI-166 hydrochloride (0-0.5μM; 1 hour; pretreatment) inhibits EGFR autophosphorylation in human pancreatic cancer cells. PKI-166 hydrochloride (0.03μM; 6 days) enhances the cytotoxicity mediated by gemcitabine. |
|
Cell Line: |
L3.6pl cells |
|
Concentration: |
0.01μM, 0.05μM, 0.5μM |
|
Incubation Time: |
1hour |
|
Result: |
Inhibited EGFR autophosphorylation in a dose-dependent manner. |
|
Cell Cytotoxicity Assay |
||
Cell Line: |
L3.6pl cells |
|
Concentration: |
0.03μM |
|
Incubation Time: |
6 days |
|
Result: |
Enhanced the cytotoxicity mediated by gemcitabine. |
|
体内研究 |
PKI-166 hydrochloride (100mg/kg; p.o.; daily; for 29 days) inhibits of pancreatic cancer growth. |
|
Animal Model: |
Male athymic nude mice with L3.6pl cells xenograft (8-12 weeks) |
|
Dosage: |
100mg/kg |
|
Administration: |
Oral administration; daily; for 29 days |
|
Result: |
Significantly decreased median tumor volume. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )